Delivery Order SPE2DB22D3016-SPE2DB25FBHJ2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,215.81 to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count supply) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December...
- The Defense Logistics Agency awarded a $30,647.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (90-count units) on September 29, 2025, with an ultimate completion date of September 30, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a $2,212.01 delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.35 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 17, 2025, with completion expected by September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $3,312.01 to AmerisourceBergen Drug Corp for supply of Kerendia 10 mg tablets (90-unit quantity) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count supply) under a firm fixed-price contract valued at $1,492.08, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order was executed on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,642.05 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packages) under a firm fixed price contract. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,568.65 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and employs firm fixed-price pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location and will...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHJ2Delivery Order
The Defense Logistics Agency awarded a $2,452.17 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count units) under a firm fixed price contract type. The order, issued on September 5, 2025, with completion targeted for September 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's competitive positioning reflects its demonstrated capability to fulfill federal medical supply requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/5/25 |